Compugen (CGEN) Tops Q3 EPS by 11c

Compugen (NASDAQ: CGEN) reported Q3 EPS of $0.01, $0.11 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $17.13 million versus the consensus estimate of $1.66 million.

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• Robinhood Ventures Fund II opens at $22.50, IPO at $25
• DA Davidson Reiterates Neutral Rating on Nebius Group (NBIS)
• Benchmark Reiterates Buy Rating on NANO Nuclear Energy (NNE)